.jpg)
1 hour ago
3
Article content
CAMBRIDGE, Mass. & TORONTO — Deep Genomics, the AI-first TechBio organization pioneering a new path for genomic medicines with its AI foundation model platform, today announced the appointment of Thong Q. Le as chair of its Board of Directors.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
“Since joining our Board in 2025, Thong has been a trusted advisor and a strong advocate for our vision,” said Brendan Frey, Founder and Chief Innovation Officer of Deep Genomics. “He brings a fresh energy and deep experience supporting the life sciences industry to the role, making him exceptionally well positioned to lead our Board as Deep Genomics continues to advance AI-driven drug discovery.”
Article content
Article content
Article content
Mr. Le joined the Deep Genomics Board of Directors in 2025, bringing more than 20 years of experience investing in the life sciences sector. Throughout his career, he has guided high-impact investments and supported deal-making efforts that have driven meaningful health outcomes. He also serves as investment director and managing partner of the Strategic Investment Fund (SIF) for the Gates Foundation, and chairman of Accelerator Life Science Partners (ALSP), a venture capital firm dedicated to building next-generation life science companies.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
As Chair, Mr. Le will help guide Deep Genomics through its next phase of growth as the company advances its internal pipeline toward clinical development, expands strategic collaborations, and further establishes its leadership at the intersection of AI, genomics, and drug discovery.
Article content
“I’m honored to take on the role of Chair of the Board of Directors at such an exciting time for Deep Genomics and the broader TechBio industry,” said Le. “Deep Genomics has built a unique platform and world-class team leading at the intersection of AI and biology. I look forward to continuing my work alongside the company as it advances its mission to transform how medicines are discovered and developed.”
Article content
Mr. Le succeeds Chip Baird, who served as Chair of the Board for the past three years. Mr. Baird will continue to support Deep Genomics as a non-executive director and will serve as Chair of the Audit Committee.
Article content
To learn more about Deep Genomics’ work and its groundbreaking impact in the realm of genomic R&D, visit www.deepgenomics.com. For those interested in joining this team of TechBio innovators, visit https://www.deepgenomics.com/careers/.
Article content
About Deep Genomics
Article content
Deep Genomics is a fully integrated AI-first TechBio company pioneering a new approach to drug discovery with its Biological Foundation Model (BioFM) platform. At the intersection of genomics, drug development, and AI, Deep Genomics brings together a world-class team of scientists, engineers, and researchers to solve complex biological challenges at scale and accelerate the discovery and development of genetic medicines to improve patient outcomes. Deep Genomics is located in Toronto, Ontario, and Cambridge, Massachusetts. For more information, visit www.deepgenomics.com and follow us on LinkedIn and Twitter.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Article content
Contacts
Article content
Media Contact
Article content
Article content
Mandy Mellinger
Article content
Article content
Fight or Flight
Article content
Article content
Article content
English (US)